Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies-Reference-Cited by-同舟云学术

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

Published:2014-06-05 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yadav Bhagwan,Pemovska Tea,Szwajda Agnieszka,Kulesskiy Evgeny,Kontro Mika,Karjalainen Riikka,Majumder Muntasir Mamun,Malani Disha,Murumägi Astrid,Knowles Jonathan,Porkka Kimmo,Heckman Caroline,Kallioniemi Olli,Wennerberg Krister,Aittokallio Tero

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep05193.pdf

Reference22 articles.

1. Heiser, L. M. et al. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc. Natl. Acad. Sci. 109, 2724–9 (2012).

2. Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570–5 (2012).

3. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–7 (2012).

4. Basu, A. et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 154, 1151–61 (2013).

5. Tyner, J. W. et al. Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening. Cancer Res. 73, 285–296 (2013).

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways;Molecular Oncology;2024-09-08

2. Knowledge graphs facilitate prediction of drug response for acute myeloid leukemia;iScience;2024-09

3. Multi-omic and functional screening reveal targetable vulnerabilities inTP53mutated multiple myeloma;2024-08-23

4. Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response;European Urology;2024-08

5. Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience;HemaSphere;2024-07